The US FDA has granted Fast Track Designation to SOTIO [...]

Novartis has agreed to acquire UK biotech Myricx Bio for [...]

InduPro has licensed Lonza’s antibody-drug conjugate technologies to support development [...]

Lonza has entered an exclusive licensing agreement with Antharis Therapeutics [...]

AmMax Bio has licensed antibody-drug conjugate technology from Lonza to [...]

Promatix Biosciences has reported preclinical data showing its cis-bispecific ADC [...]

SOTIO Biotech has reported positive preclinical results for SOT106, its [...]

Heidelberg Pharma has reported further clinical activity from its Phase [...]

Pheon Therapeutics, a clinical-stage antibody-drug conjugate (ADC) specialist, has appointed [...]

Takeda’s antibody-drug conjugate gains second frontline indication following positive Phase [...]